On the other hand, KB Home beat analysts' revenue expectations during the quarter. In addition, its full-year revenue guidance came in above Wall Street's estimates. Overall, this was a mixed but ...

Homebuilder KB Home (NYSE:KBH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.5% year on year to $2 billion. On the other hand, the company’s full-year revenue guidance ...

Homebuilder KB Home (NYSE:KBH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.5% year on year to $2 ...

Most U.S. stocks rose following an encouraging update on inflation, but drops for Eli Lilly and some other influential stocks kept indexes in check ...

On Wall Street, KB Home rose 4.8% after delivering a better profit for its latest quarter than analysts expected. The rise in Treasury yields has made mortgages more expensive, but Chief Executive ...

KB Home is up 4.1% since the beginning of the year, but at $67.25 per share, it is still trading 25% below its 52-week high of $89.63 from September 2024. Investors who bought $1,000 worth of KB ...

In a report released today, Michael Rehaut from J.P. Morgan maintained a Buy rating on Mohawk (MHK – Research Report), with a price target of ...

NEW YORK — Drops for Eli Lilly and other influential companies are weighing on U.S. indexes Tuesday, even though most of the market is rising following an encouraging update on inflation.